Source:http://linkedlifedata.com/resource/pubmed/id/16686304
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2006-5-11
|
pubmed:abstractText |
The most serious problem in peritoneal dialysis (PD) is the risk of final complication by encapsulating peritoneal sclerosis (EPS) because of peritoneal deterioration. Markers useful for the noninvasive evaluation ofperitoneal deterioration are therefore required. In this multicenter prospective study of stable PD patients, we compared the dialysate-to-plasma (D/P) concentration ratios of albumin, immunoglobulin G, and c2-macroglobulin, and effluent levels of interleukin 6 (IL-6) and fibrinogen/fibrin degradation products (FDPs) to clarify the relationship between inflammation, fibrinolysis markers, and permeability to large molecules. At the beginning of the present study, significantly positive correlations were noted between the IL-6 and FDP concentrations and the D/P ratios of albumin and a2-macroglobulin. In addition, a significantly positive correlation was noted between the FDP and IL-6 concentrations. However, the D/P ratio of creatinine obtained by peritoneal equilibration test did not positively correlate with those markers. Moreover, a significantly positive correlation was noted between changes in the effluent concentrations of FDPs and IL-6 and in permeability markers for large molecules. The effluent IL-6 and FDP concentrations reflect a chronic inflammatory state in the peritoneum, which is associated with increased permeability to large molecules. In individual PD patients, careful observation of the clinical course and evaluation of changes in such markers are expected to predict peritoneal deterioration and the development of EPS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Albumins,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Fibrinogen Degradation...,
http://linkedlifedata.com/resource/pubmed/chemical/Hemodialysis Solutions,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Macroglobulins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1197-8554
|
pubmed:author |
pubmed-author:ChohShisohS,
pubmed-author:FujimoriAkiraA,
pubmed-author:KawanishiHidekiH,
pubmed-author:KimMasaoM,
pubmed-author:MinakuchiJunJ,
pubmed-author:NaitoHidemuneH,
pubmed-author:NumataAkiraA,
pubmed-author:Peritoneal Effluent Study Group Japan,
pubmed-author:TakemotoYoshiakiY,
pubmed-author:TomoTadashiT,
pubmed-author:TsuchidaKenjiK,
pubmed-author:YamamotoTadashiT
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
134-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16686304-Albumins,
pubmed-meshheading:16686304-Ascitic Fluid,
pubmed-meshheading:16686304-Biological Markers,
pubmed-meshheading:16686304-Female,
pubmed-meshheading:16686304-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:16686304-Hemodialysis Solutions,
pubmed-meshheading:16686304-Humans,
pubmed-meshheading:16686304-Immunoglobulin G,
pubmed-meshheading:16686304-Interleukin-6,
pubmed-meshheading:16686304-Male,
pubmed-meshheading:16686304-Middle Aged,
pubmed-meshheading:16686304-Peritoneal Dialysis,
pubmed-meshheading:16686304-Peritoneum,
pubmed-meshheading:16686304-Sclerosis,
pubmed-meshheading:16686304-alpha-Macroglobulins
|
pubmed:year |
2005
|
pubmed:articleTitle |
Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan.
|
pubmed:affiliation |
Tsuchiya General Hospital, Hiroshima, Japan. h-kawanishi@tsuchiya-hp.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|